203 related articles for article (PubMed ID: 27861202)
1. Novel approaches to early detection of endometrial cancer.
Bagaria M; Shields E; Bakkum-Gamez JN
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):40-46. PubMed ID: 27861202
[TBL] [Abstract][Full Text] [Related]
2. New perspectives on screening and early detection of endometrial cancer.
Costas L; Frias-Gomez J; Guardiola M; Benavente Y; Pineda M; Pavón MÁ; Martínez JM; Climent M; Barahona M; Canet J; Paytubi S; Salinas M; Palomero L; Bianchi I; Reventós J; Capellà G; Diaz M; Vidal A; Piulats JM; Aytés Á; Ponce J; Brunet J; Bosch FX; Matias-Guiu X; Alemany L; de Sanjosé S;
Int J Cancer; 2019 Dec; 145(12):3194-3206. PubMed ID: 31199503
[TBL] [Abstract][Full Text] [Related]
3. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
4. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
5. Repurposing the vaginal tampon for endometrial cancer detection.
Bakkum-Gamez JN
Biomark Med; 2015; 9(8):715-7. PubMed ID: 26230218
[No Abstract] [Full Text] [Related]
6. Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma.
Djordjevic B; Broaddus RR
Surg Pathol Clin; 2016 Jun; 9(2):289-99. PubMed ID: 27241109
[TBL] [Abstract][Full Text] [Related]
7. Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.
Ambeba E; Linkov F
Future Oncol; 2011 Dec; 7(12):1399-414. PubMed ID: 22112316
[TBL] [Abstract][Full Text] [Related]
8. The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome.
Helder-Woolderink JM; De Bock GH; Sijmons RH; Hollema H; Mourits MJ
Gynecol Oncol; 2013 Nov; 131(2):304-8. PubMed ID: 23769810
[TBL] [Abstract][Full Text] [Related]
9. Lynch Syndrome: Female Genital Tract Cancer Diagnosis and Screening.
Mills AM; Longacre TA
Surg Pathol Clin; 2016 Jun; 9(2):201-14. PubMed ID: 27241104
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation markers for endometrial cancer detection in minimally invasive samples: a systematic review.
den Helder RV; Wever BM; van Trommel JA; Ket JC; Bleeker MC; Steenbergen RD; van Trommel NE
Epigenomics; 2020 Sep; 12(18):1661-1672. PubMed ID: 32938224
[No Abstract] [Full Text] [Related]
11. A Pap-Based Test to Detect Endometrial and Ovarian Cancers Early.
Abbasi J
JAMA; 2018 May; 319(18):1853. PubMed ID: 29800996
[No Abstract] [Full Text] [Related]
12. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.
van den Helder R; Wever BMM; van Trommel NE; van Splunter AP; Mom CH; Kasius JC; Bleeker MCG; Steenbergen RDM
Clin Epigenetics; 2020 Nov; 12(1):165. PubMed ID: 33143739
[TBL] [Abstract][Full Text] [Related]
13. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.
Long Q; Peng Y; Tang Z; Wu C
Int J Clin Exp Pathol; 2014; 7(10):7297-303. PubMed ID: 25400828
[TBL] [Abstract][Full Text] [Related]
14. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez JN; Wentzensen N; Maurer MJ; Hawthorne KM; Voss JS; Kroneman TN; Famuyide AO; Clayton AC; Halling KC; Kerr SE; Cliby WA; Dowdy SC; Kipp BR; Mariani A; Oberg AL; Podratz KC; Shridhar V; Sherman ME
Gynecol Oncol; 2015 Apr; 137(1):14-22. PubMed ID: 25677060
[TBL] [Abstract][Full Text] [Related]
15. Gynecological surveillance in high risk women.
Dilley J; Gentry-Maharaj A; Menon U
Minerva Ginecol; 2016 Oct; 68(5):497-508. PubMed ID: 26930388
[TBL] [Abstract][Full Text] [Related]
16. George Papanicolaou's Efforts to Develop Novel Cytologic Methods for the Early Diagnosis of Endometrial Carcinoma.
Austin RM
Acta Cytol; 2017; 61(4-5):281-298. PubMed ID: 28693005
[TBL] [Abstract][Full Text] [Related]
17. Defining a mutational signature for endometrial cancer screening and early detection.
Costas L; Palomero L; Benavente Y; Guardiola M; Frias-Gomez J; Pavón MÁ; Climent M; Martinez JM; Barahona M; Salinas M; Pineda M; Bianchi I; Reventós J; Capellà G; Diaz M; Vidal A; Piulats JM; Ponce J; Brunet J; Bosch FX; Matias-Guiu X; Alemany L; de Sanjosé S; Aytés Á;
Cancer Epidemiol; 2019 Aug; 61():129-132. PubMed ID: 31238232
[TBL] [Abstract][Full Text] [Related]
18. Should we screen for endometrial cancer?
Vergote I; Amant F; Timmerman D
Lancet Oncol; 2011 Jan; 12(1):4-5. PubMed ID: 21147031
[No Abstract] [Full Text] [Related]
19. Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.
Lin DI; Hecht JL
Int J Surg Pathol; 2016 Jun; 24(4):297-305. PubMed ID: 26842347
[TBL] [Abstract][Full Text] [Related]
20. Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer.
Banno K; Nogami Y; Kisu I; Yanokura M; Umene K; Masuda K; Kobayashi Y; Yamagami W; Susumu N; Aoki D
Int J Mol Sci; 2013 Jun; 14(6):12123-37. PubMed ID: 23743825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]